Turn sound waves into better diagnostics and cell therapy
At AcouSort, we use acoustofluidics, a combination of sound waves and microfluidics, to handle cells and particles gently and without labels. Our technology grew out of more than 20 years of research at the Department of Biomedical Engineering at Lund University. Today it’s used in research instruments such as AcouWash and AcouTrap and will revolutionize sample processing within diagnostics, biomarker research and cell therapy manufacturing.
We’re now looking for an R&D Scientist who can support taking acoustofluidics devices from simulation through validated prototype to product lunch.
What you’ll do
Who you are
We offer
A key role in an ambitious team, where your work goes straight into products used by researchers, clinics and the cell therapy industry.
Interested? Please send your application to [email protected]. Applications are reviewed continuously.
About AcouSort
AcouSort is a medical technology company developing critical components for instrumentation used in the diagnostics, analytics, and cell therapy processing markets. AcouSort’s components allow for automated refinement of biological samples such as blood or cell preparations, providing instrumentation manufacturers with a state-of-the-art ability to integrate sample processing steps that traditionally must be performed manually.
AcouSort’s strategy is to use our innovative technology to revolutionize today’s healthcare by providing a solution to automate and integrate sample processing steps, allowing for a new generation of medical devices to be developed. Through collaborations with leading Life Science companies our integrated technology will eliminate manual handling steps while saving time, money, and ultimately – lives.
Our core technology builds on more than 20 years of acoustofluidics research and development headed by Thomas Laurell, professor at Lund University at the Department of Biomedical Engineering and co-founder and board member of AcouSort. The company is listed on Nasdaq First North Growth Market in Stockholm.